The Combination of Molecular Adjuvant CCL35.2 and DNA Vaccine Significantly Enhances the Immune Protection of Against CyHV-2 Infection

Overview

Journal Vaccines (Basel)

Date 2020 Oct 6

PMID 33019519

Citations 10

Authors

Xingchen Huo

Chengjian Fan

Taoshan Ai

Jianguo Su

Affiliations

Soon will be listed here.

Abstract

Cyprinid herpesvirus 2 (CyHV-2) infection results in huge economic losses in gibel carp () industry. In this study, we first constructed recombinant plasmids pcORF25 and pcCCL35.2 as DNA vaccine and molecular adjuvant against CyHV-2, respectively, and confirmed that both recombinant plasmids could be effectively expressed in vitro and in vivo. Then, the vaccination and infection experiments ( = 50) were set as seven groups. The survival rate (70%) in ORF25/CCL35.2 group was highest. The highest specific antibody levels were found in ORF25/CCL35.2 group in major immune tissues by qRT-PCR, and confirmed in serum by ELISA assay, antibody neutralization titer, and serum incubation-infection experiments. Three crucial innate immune indices, namely C3 content, lysozyme, and total superoxide dismutase (TSOD) activities, were highest in ORF25/CCL35.2 group in serum. pcORF25/pcCCL35.2 can effectively up-regulate mRNA expressions of some important immune genes (IL-1β, IL-2, IFN-γ2, and viperin), and significantly suppress CyHV-2 replication in head kidney and spleen tissues. The minimal tissue lesions can be seen in ORF25/CCL35.2 group in gill, spleen, and trunk kidney tissues by histopathological examination. The results indicated that the combination of DNA vaccine pcORF25 and molecular adjuvant pcCCL35.2 is an effective method against CyHV-2 infection, suggesting a feasible strategy for the control of fish viral diseases.

Citing Articles

Genomic and molecular characterization of a cyprinid herpesvirus 2 YC-01 strain isolated from gibel carp.

Yang J, Xiao S, Lu L, Wang H, Jiang Y Heliyon. 2024; 10(13):e32811.

PMID: 39035518 PMC: 11259805. DOI: 10.1016/j.heliyon.2024.e32811.

Adjuvant Effects of a CC Chemokine for Enhancing the Efficacy of an Inactivated Vaccine in Nile Tilapia ().

Soontara C, Uchuwittayakul A, Kayansamruaj P, Amparyup P, Wongpanya R, Srisapoome P Vaccines (Basel). 2024; 12(6).

PMID: 38932370 PMC: 11209360. DOI: 10.3390/vaccines12060641.

Generation and Characterization of ORF55/ORF57-Deleted Recombinant 2 Mutants with Chimeric Capsid Protein Gene of Grouper Nervous Necrosis Virus.

Feng Z, Cheng W, Ma M, Yu C, Zhang Y, Lu L Vaccines (Basel). 2024; 12(1).

PMID: 38250856 PMC: 10820899. DOI: 10.3390/vaccines12010043.

Oral administration of hepcidin and chitosan benefits growth, immunity, and gut microbiota in grass carp ().

Zhou J, Feng M, Zhang W, Kuang R, Zou Q, Su J Front Immunol. 2023; 13:1075128.

PMID: 36591242 PMC: 9798086. DOI: 10.3389/fimmu.2022.1075128.

Current status and development prospects of aquatic vaccines.

Du Y, Hu X, Miao L, Chen J Front Immunol. 2022; 13:1040336.

PMID: 36439092 PMC: 9684733. DOI: 10.3389/fimmu.2022.1040336.

References

Kutzler M, Weiner D . DNA vaccines: ready for prime time?. Nat Rev Genet. 2008; 9(10):776-88. PMC: 4317294. DOI: 10.1038/nrg2432. View

Garlanda C, Dinarello C, Mantovani A . The interleukin-1 family: back to the future. Immunity. 2013; 39(6):1003-18. PMC: 3933951. DOI: 10.1016/j.immuni.2013.11.010. View

Zhang J, Zhang B, Sun L . P247 and p523: two in vivo-expressed megalocytivirus proteins that induce protective immunity and are essential to viral infection. PLoS One. 2015; 10(3):e0121282. PMC: 4376877. DOI: 10.1371/journal.pone.0121282. View

Lillard Jr J, Singh U, Boyaka P, Singh S, Taub D, McGhee J . MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity. Blood. 2002; 101(3):807-14. DOI: 10.1182/blood-2002-07-2305. View

Zhou Y, Jiang N, Ma J, Fan Y, Zhang L, Xu J . Protective immunity in gibel carp, Carassius gibelio of the truncated proteins of cyprinid herpesvirus 2 expressed in Pichia pastoris. Fish Shellfish Immunol. 2015; 47(2):1024-31. DOI: 10.1016/j.fsi.2015.11.012. View

Nguyen-Hoai T, Pham-Duc M, Gries M, Dorken B, Pezzutto A, Westermann J . CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor model. Cancer Gene Ther. 2016; 23(6):162-7. DOI: 10.1038/cgt.2016.9. View

Chang C, Gu J, Robertsen B . Protective effect and antibody response of DNA vaccine against salmonid alphavirus 3 (SAV3) in Atlantic salmon. J Fish Dis. 2017; 40(12):1775-1781. DOI: 10.1111/jfd.12644. View

Garza-Morales R, Perez-Trujillo J, Martinez-Jaramillo E, Saucedo-Cardenas O, Loera-Arias M, Garcia-Garcia A . A DNA Vaccine Encoding SA-4-1BBL Fused to HPV-16 E7 Antigen Has Prophylactic and Therapeutic Efficacy in a Cervical Cancer Mouse Model. Cancers (Basel). 2019; 11(1). PMC: 6356763. DOI: 10.3390/cancers11010096. View

Boshra H, Li J, Sunyer J . Recent advances on the complement system of teleost fish. Fish Shellfish Immunol. 2005; 20(2):239-62. DOI: 10.1016/j.fsi.2005.04.004. View

10.

Su H, Su J . Cyprinid viral diseases and vaccine development. Fish Shellfish Immunol. 2018; 83:84-95. PMC: 7118463. DOI: 10.1016/j.fsi.2018.09.003. View

11.

Saade F, Petrovsky N . Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines. 2012; 11(2):189-209. PMC: 3293989. DOI: 10.1586/erv.11.188. View

12.

Xu J, Zeng L, Zhang H, Zhou Y, Ma J, Fan Y . Cyprinid herpesvirus 2 infection emerged in cultured gibel carp, Carassius auratus gibelio in China. Vet Microbiol. 2013; 166(1-2):138-44. DOI: 10.1016/j.vetmic.2013.05.025. View

13.

Chapman R, Rybicki E . Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation. Vaccines (Basel). 2019; 7(2). PMC: 6632145. DOI: 10.3390/vaccines7020050. View

14.

Liao Z, Wan Q, Xiao X, Ji J, Su J . A systematic investigation on the composition, evolution and expression characteristics of chemokine superfamily in grass carp Ctenopharyngodon idella. Dev Comp Immunol. 2018; 82:72-82. DOI: 10.1016/j.dci.2018.01.002. View

15.

Gui J, Zhou L . Genetic basis and breeding application of clonal diversity and dual reproduction modes in polyploid Carassius auratus gibelio. Sci China Life Sci. 2010; 53(4):409-15. DOI: 10.1007/s11427-010-0092-6. View

16.

Zhu B, Zhang C, Zhao Z, Wang G . Targeted Delivery of Mannosylated Nanoparticles Improve Prophylactic Efficacy of Immersion Vaccine against Fish Viral Disease. Vaccines (Basel). 2020; 8(1). PMC: 7157632. DOI: 10.3390/vaccines8010087. View

17.

Tonheim T, Bogwald J, Dalmo R . What happens to the DNA vaccine in fish? A review of current knowledge. Fish Shellfish Immunol. 2008; 25(1-2):1-18. DOI: 10.1016/j.fsi.2008.03.007. View

18.

Wang T, Hu Y, Wangkahart E, Liu F, Wang A, Zahran E . Interleukin (IL)-2 Is a Key Regulator of T Helper 1 and T Helper 2 Cytokine Expression in Fish: Functional Characterization of Two Divergent Paralogs in Salmonids. Front Immunol. 2018; 9:1683. PMC: 6070626. DOI: 10.3389/fimmu.2018.01683. View

19.

Pinto A, Reyes-Sandoval A, Ertl H . Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus. Cell Immunol. 2003; 224(2):106-13. DOI: 10.1016/j.cellimm.2003.08.006. View

20.

Wei C, Iida H, Chuah Q, Tanaka M, Kato G, Sano M . Persistence of cyprinid herpesvirus 2 in asymptomatic goldfish Carassius auratus (L.) that survived an experimental infection. J Fish Dis. 2019; 42(6):913-921. DOI: 10.1111/jfd.12996. View